In experiments of monitoring ATP release levels, we also observed a consistent trend between the amount of ATP released by CFRI nanoparticles and the expression levels of CRT and HMGB1 release, once again confirming the effectiveness of CFRI nanoparticles in inducing ICD effects (Fig. 6E). This evidence concerns the gene CALR and impulse control disorder.